{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:26:33Z","timestamp":1790083593066,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11912-022-01198-z","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T13:02:36Z","timestamp":1642770156000},"page":"209-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic"],"prefix":"10.1007","volume":"24","author":[{"given":"Abril Adriana","family":"Arellano-Llamas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Vela-Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Hernandez-Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"1198_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727\u201333. https:\/\/doi.org\/10.1056\/NEJMoa2001017.","journal-title":"N Engl J Med"},{"key":"1198_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507\u201313. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7.","journal-title":"Lancet"},{"key":"1198_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijid.2020.09.1464","volume":"101","author":"G Meyerowitz-Katz","year":"2020","unstructured":"Meyerowitz-Katz G, Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates. Int J Infect Dis. 2020;101:138\u201348. https:\/\/doi.org\/10.1016\/j.ijid.2020.09.1464.","journal-title":"Int J Infect Dis"},{"key":"1198_CR4","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/S0140-6736(20)30558-4","volume":"395","author":"T Wang","year":"2020","unstructured":"Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, et al. Comorbidities and multiorgan injuries in the treatment of COVID-19. Lancet. 2020;395:e52. https:\/\/doi.org\/10.1016\/S0140-6736(20)30558-4.","journal-title":"Lancet"},{"key":"1198_CR5","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41375-020-0836-7","volume":"34","author":"W He","year":"2020","unstructured":"He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, et al. COVID-19 in persons with haematological cancers. Leukemia. 2020;34:1637\u201345. https:\/\/doi.org\/10.1038\/s41375-020-0836-7.","journal-title":"Leukemia"},{"key":"1198_CR6","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1111\/bjh.16801","volume":"190","author":"F Mart\u00edn-Moro","year":"2020","unstructured":"Mart\u00edn-Moro F, Marquet J, Piris M, Michael BM, S\u00e1ez AJ, Corona M, et al. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. Br J Haematol. 2020;190:e16-20. https:\/\/doi.org\/10.1111\/bjh.16801.","journal-title":"Br J Haematol"},{"key":"1198_CR7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/ajh.24086","volume":"90","author":"M Al-Hamadani","year":"2015","unstructured":"Al-Hamadani M, Habermann TM, Cerhan JR, Macon WR, Maurer MJ, Go RS. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011. Am J Hematol. 2015;90:790\u20135. https:\/\/doi.org\/10.1002\/ajh.24086.","journal-title":"Am J Hematol"},{"key":"1198_CR8","doi-asserted-by":"publisher","unstructured":"Alrawashdh N, Sweasy J, Erstad B, McBride A, Persky DO, Abraham I. Survival trends in chronic lymphocytic leukemia across treatment eras: US SEER database analysis (1985\u20132017). Ann Hematol. 2021. https:\/\/doi.org\/10.1007\/s00277-021-04600-1 Online ahead of print.","DOI":"10.1007\/s00277-021-04600-1"},{"key":"1198_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/10428194.2012.706285","volume":"54","author":"JA Freeman","year":"2013","unstructured":"Freeman JA, Crassini KR, Best OG, Forsyth CJ, Mackinlay NJ, Han P, et al. Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2013;54:99\u2013104. https:\/\/doi.org\/10.3109\/10428194.2012.706285.","journal-title":"Leuk Lymphoma"},{"key":"1198_CR10","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.vaccine.2021.01.001","volume":"39","author":"JA Whitaker","year":"2021","unstructured":"Whitaker JA, Parikh SA, Shanafelt TD, Kay NE, Kennedy RB, Grill DE, et al. The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL). Vaccine. 2021;39:1122\u201330. https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.001.","journal-title":"Vaccine"},{"key":"1198_CR11","doi-asserted-by":"publisher","first-page":"106520","DOI":"10.1016\/j.leukres.2021.106520","volume":"102","author":"IG Solman","year":"2021","unstructured":"Solman IG, Blum LK, Burger JA, Kipps TJ, Dean JP, James DF, et al. Impact of long-term ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemia. Leuk Res. 2021;102:106520. https:\/\/doi.org\/10.1016\/j.leukres.2021.106520.","journal-title":"Leuk Res"},{"key":"1198_CR12","doi-asserted-by":"publisher","unstructured":"Cuneo A, Rigolin GM, Coscia M, Quaresmini G, Scarf\u00f2 L, Mauro FR, et al. Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report. Hematol Oncol. 2021. https:\/\/doi.org\/10.1002\/hon.2899. Online ahead of print. This survey analyzed the course of 9930 patients with CLL treated during the COVID-19 emergency in 33 centers across Italy. The reported prevalence of symptomatic COVID-19 cases in CLL patients was similar to the average population. COVID-19 situation in hospitals impacted on treatment routine of CLL patients.","DOI":"10.1002\/hon.2899"},{"key":"1198_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533\u20134. https:\/\/doi.org\/10.1016\/S1473-3099(20)30120-1.","journal-title":"Lancet Infect Dis"},{"key":"1198_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jinf.2020.03.041","volume":"80","author":"L Fu","year":"2020","unstructured":"Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect. 2020;80:656\u201365. https:\/\/doi.org\/10.1016\/j.jinf.2020.03.041.","journal-title":"J Infect"},{"key":"1198_CR15","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1038\/s41375-020-0959-x","volume":"34","author":"L Scarf\u00f2","year":"2020","unstructured":"Scarf\u00f2 L, Chatzikonstantinou T, Rigolin GM, Quaresmini G, Motta M, Vitale C, et al. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. Leukemia. 2020;34:2354\u201363. https:\/\/doi.org\/10.1038\/s41375-020-0959-x. This retrospective international multicenter study characterized the course of COVID-19 in patients with CLL. Severe COVID-19 was associated with age \u226565 years. Hospitalization rate for severe COVID-19 was significantly lower for patients on ibrutinib treatment.","journal-title":"Leukemia"},{"key":"1198_CR16","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1182\/blood.2020006965","volume":"136","author":"AR Mato","year":"2020","unstructured":"Mato AR, Roeker LE, Lamanna N, Allan JN, Leslie L, Pagel JM, et al. Outcomes of COVID-19 in patients with CLL: a multicenter international experience. Blood. 2020;136:1134\u201343. https:\/\/doi.org\/10.1182\/blood.2020006965. This study included data from 198 CLL patients diagnosed with symptomatic COVID-19 across 43 international centers. They found a high risk of death in CLL patients admitted with COVID-19. Treatment with BTKi's at COVID-19 diagnosis did not modify survival.","journal-title":"Blood"},{"key":"1198_CR17","doi-asserted-by":"publisher","unstructured":"Roeker LE, Eyre TA, Thompson MC, Lamanna N, Coltoff A, Davids MS, et al. COVID-19 in patients with CLL: improved survival outcomes and update on management strategies. Blood. 2021:blood.2021011841. https:\/\/doi.org\/10.1182\/blood.2021011841. Online ahead of print. This retrospective study from 45 centers identified a high case fatality rate in CLL patients infected with SARS-CoV-2. Older age and frailty were associated with poorer outcomes. Mortality declined over time.","DOI":"10.1182\/blood.2021011841"},{"key":"1198_CR18","doi-asserted-by":"publisher","first-page":"e222","DOI":"10.7861\/clinmed.2020-0423","volume":"20","author":"AD Kerr","year":"2020","unstructured":"Kerr AD, Stacpoole SR. Coronavirus in the elderly: a late lockdown UK cohort. Clin Med. 2020;20:e222\u20138. https:\/\/doi.org\/10.7861\/clinmed.2020-0423.","journal-title":"Clin Med"},{"key":"1198_CR19","doi-asserted-by":"publisher","unstructured":"Castro Dopico X, Ols S, Lor\u00e9 K, Karlsson Hedestam GB. Immunity to SARS-CoV-2 induced by infection or vaccination. J Intern Med. 2021. https:\/\/doi.org\/10.1111\/joim.13372. Online ahead of print.","DOI":"10.1111\/joim.13372"},{"key":"1198_CR20","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1038\/s41467-020-19943-y","volume":"11","author":"K Li","year":"2020","unstructured":"Li K, Huang B, Wu M, Zhong A, Li L, Cai Y, et al. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Nat Commun. 2020;11:6044. https:\/\/doi.org\/10.1038\/s41467-020-19943-y.","journal-title":"Nat Commun"},{"key":"1198_CR21","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1038\/s41375-020-01030-2","volume":"34","author":"LE Roeker","year":"2020","unstructured":"Roeker LE, Knorr DA, Pessin MS, Ramanathan LV, Thompson MC, Leslie LA, et al. Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia. Leukemia. 2020;34:3047\u20139. https:\/\/doi.org\/10.1038\/s41375-020-01030-2.","journal-title":"Leukemia"},{"key":"1198_CR22","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","volume":"384","author":"N Dagan","year":"2021","unstructured":"Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, et al. BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384:1412\u201323. https:\/\/doi.org\/10.1056\/NEJMoa2101765.","journal-title":"N Engl J Med"},{"key":"1198_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1182\/blood.2020008758","volume":"137","author":"C Pleyer","year":"2021","unstructured":"Pleyer C, Ali MA, Cohen JI, Tian X, Soto S, Ahn IE, et al. Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines. Blood. 2021;137:185\u20139. https:\/\/doi.org\/10.1182\/blood.2020008758. This manuscript reported the results of two open-label, single-arm clinical trials to measure the effect of BTK inhibitors on the immune response to recombinant hepatitis B and zoster vaccines. This study opened the discussion of the efficacy of other vaccines during CLL-directed therapy.","journal-title":"Blood"},{"key":"1198_CR24","doi-asserted-by":"publisher","unstructured":"Roeker LE, Knorr DA, Thompson MC, Nivar M, Lebowitz S, Peters N, et al. COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia. Leukemia. 2021:1\u20133. https:\/\/doi.org\/10.1038\/s41375-021-01270-w. Online ahead of print. This is one of the first studies that reported the serologic response to COVID-19 vaccines in patients with chronic lymphocytic leukemia. Frequency of detectable anti-SARS-CoV-2 S1\/S2 antibodies was low, particularly in patients receiving CLL-directed therapy.","DOI":"10.1038\/s41375-021-01270-w"},{"key":"1198_CR25","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1182\/blood.2021011568","volume":"137","author":"Y Herishanu","year":"2021","unstructured":"Herishanu Y, Avivi I, Aharon A, Shefer G, Levi S, Bronstein Y, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021;137:3165\u201373. https:\/\/doi.org\/10.1182\/blood.2021011568. This study compared the humoral immune responses to a messenger RNA COVID-19 vaccine between CLL patients and healthy controls. Efficacy was impaired by disease activity and treatment.","journal-title":"Blood"},{"key":"1198_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41408-021-00528-x","volume":"11","author":"H Parry","year":"2021","unstructured":"Parry H, McIlroy G, Bruton R, Ali M, Stephens C, Damery S, et al. Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia. Blood Cancer J. 2021;11:136. https:\/\/doi.org\/10.1038\/s41408-021-00528-x. They compared spike-specific antibody responses to vaccination between 299 patients with CLL and healthy donors. Active treatment with BTK inhibitors was independently associated with a lack of antibody response. Titers of antibodies are significantly lower in CCL patients.","journal-title":"Blood Cancer J"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-022-01198-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-022-01198-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-022-01198-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T06:27:19Z","timestamp":1645165639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-022-01198-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1198"],"URL":"https:\/\/doi.org\/10.1007\/s11912-022-01198-z","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"22 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}